title: Severe hypophosphataemia after intravenous iron administration.
abstract: Iron deficiency is common and can be effectively treated with parenteral iron infusion. We report a case of an iron-deficient and vitamin D-deficient woman who developed severe symptomatic hypophosphataemia following intravenous ferric carboxymaltose administration. We stress the need of increased awareness of this potential complication among physicians. Patients should be informed of this complication and instructed to report for follow-up if they experience new musculoskeletal symptoms or worsening of tiredness. As severe hypophosphataemia is usually symptomatic, we recommend screening symptomatic patients for this complication. Recognising and treating the possible exacerbating factors, especially vitamin D deficiency, might be a simple measure to mitigate this complication.
authors.affiliation: Division of Endocrinology, University Hospital Zürich, Zürich, Switzerland.
authors.forename: Gurpreet
authors.initials: G
authors.lastname: Anand
authors.affiliation: Division of Endocrinology, University Hospital Zürich, Zürich, Switzerland.
authors.forename: Christoph
authors.initials: C
authors.lastname: Schmid
mesh_terms: D061605:Administration, Intravenous; D000328:Adult; D018798:Anemia, Iron-Deficiency / Q000188:drug therapy*; D005260:Female; D006801:Humans; D017674:Hypophosphatemia / Q000139:chemically induced*; D007501:Iron / Q000008:administration & dosage / Q000009:adverse effects*; D014808:Vitamin D Deficiency / Q000150:complications
chemical_list: D007501:Iron